Stocktoria
60 DEGREES PHARMACEUTICALS, INC. SXTP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-07-12
60 DEGREES PHARMACEUTICALS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 22.3% | 36.7% | -87.1% | -93.7% |
| Operating margin | -771.6% | -1599.0% | -2032.8% | -784.2% |
| Net margin | -732.5% | -1308.0% | -1485.1% | -2769.5% |
| FCF margin | -695.1% | -946.7% | -1814.3% | — |
| Return on assets | -137.3% | -138.0% | -48.4% | -476.5% |
| Return on equity | -212.7% | -196.9% | -77.3% | 25.6% |
| Debt / equity | 0.04× | 0.04× | 0.03× | -0.70× |
| Current ratio | 2.66 | 3.25 | 2.55 | 0.05 |
| Revenue growth | 65.5% | 139.6% | 13.6% | — |
Source: SEC EDGAR filings · CIK 0001946563 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.